The idea that hospitals are marking up prices on medicines -- not by a little, but by a whole lot -- is not a new one. PhRMA has been waving

Tyson Foods has 140,000 employees, which is a huge number of people in most contexts, but not that big a number, if we’re being honest, in the context of U.S.

I’m usually loathe to link to articles that are behind particularly high paywalls, but I’m going to make an exception. If you subscribe to BioCentury, check out this piece on

There are two weirdly similar stories out today on how to shop thoughtfully for low-priced medicines, one from USA Today and one from the Boston Globe. These two pieces are

In some ways, I’ve given up on my dream that stories about beginning-of-the-year price changes for prescription drugs will be thoughtful. Yes, it would be nice if the stories were

Lord, this is lousy.  The New York Times is out with an explainer on why the United States has high drug prices. To the extent that there are myths around

Yesterday, feeling snarky, I asked a rhetorical question: “What has United done for anyone lately?” The point, in the context of yet another set of record profits for UnitedHealth Group,

/ So UnitedHealth Group made about $5.5 billion in pure profit last quarter, with revenues nearing $100 billion. A huge chunk of that came from its Optum unit. The company’s

Programming Note: Cost Curve is probably off tomorrow, almost certainly off Friday, and definity off Monday. I’ll catch everyone up next week. J.P. Morgan put, arguably, the two hottest companies

The thing about J.P. Morgan is that you can draw overbroad conclusions after just 24 hours. The deals have been announced. Bellwether companies have provided a baseline. Attendees are not